amphetamine has been researched along with tamoxifen in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 6 (46.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Anderson, LI; Dluzen, DE; McDermott, JL | 1 |
Becker, JB; Jackson, LR; Xiao, L | 1 |
Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
Dogra, S; Einat, H; Manji, HK; Szabo, ST; Yuan, P | 1 |
Andreatini, R; Baretta, IP; Gustafson, L; Ninomiya, EM; Rodrigues, AL; Sabioni, P | 1 |
Bavaresco, DV; Bobsin, TS; Budni, J; de Freitas, KV; Gonçalves, CL; Quevedo, J; Streck, EL; Valvassori, SS | 1 |
Chen, CC; Chiang, WW; Chien, YC; Lien, CC; Lin, SH; Liu, YZ | 1 |
Altshuler, R; Carpenter, C; Gnegy, ME; Guptaroy, B; Jutkiewicz, E; Kennedy, RT; Showalter, HD; Sorenson, RJ; Zestos, AG | 1 |
Gnegy, ME; Guptaroy, B; Jones, KT; Mikelman, SR; Reith, MEA; Schmitt, KC; Zhen, J | 1 |
1 review(s) available for amphetamine and tamoxifen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for amphetamine and tamoxifen
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Interactive effects of tamoxifen and oestrogen upon the nigrostriatal dopaminergic system: long-term treatments.
Topics: Amphetamine; Animals; Corpus Striatum; Culture Techniques; Dopamine; Drug Interactions; Estradiol; Female; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Tamoxifen; Time; Uterus | 1999 |
The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: pharmacological and behavioral evidence.
Topics: Amphetamine; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Sexual Behavior, Animal; Tamoxifen | 2003 |
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Topics: Amphetamine; Animals; Anthracenes; Antimanic Agents; Blotting, Western; Carbamazepine; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Corticosterone; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Enzymologic; Imidazoles; Indoles; Inositol; Lithium; Maleimides; Protein Kinase C; Protein Kinase C-alpha; Pyridines; Receptors, Glucocorticoid; Tamoxifen; Tetradecanoylphorbol Acetate; Valproic Acid | 2004 |
Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder.
Topics: Amphetamine; Animals; Behavior, Animal; Bipolar Disorder; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Exploratory Behavior; GAP-43 Protein; Male; Motor Activity; Multivariate Analysis; Phosphorylation; Rats; Rats, Sprague-Dawley; Tamoxifen; Time Factors | 2007 |
The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Behavior, Animal; Benzophenanthridines; Contraceptives, Oral, Synthetic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hyperkinesis; Lithium Carbonate; Medroxyprogesterone; Mice; Protein Kinase C; Tamoxifen | 2008 |
Effects of tamoxifen on tricarboxylic acid cycle enzymes in the brain of rats submitted to an animal model of mania induced by amphetamine.
Topics: Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Brain; Citric Acid Cycle; Disease Models, Animal; Male; Motor Activity; Rats; Rats, Wistar; Tamoxifen | 2014 |
Genetic mapping of ASIC4 and contrasting phenotype to ASIC1a in modulating innate fear and anxiety.
Topics: Acid Sensing Ion Channels; Amphetamine; Animals; Anxiety; Body Composition; Eating; Estrogen Antagonists; Excitatory Amino Acid Agonists; Fear; Humans; Hyperkinesis; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nervous System; Nociception; Seizures; Tamoxifen; Time Factors | 2015 |
Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Male; Motor Activity; Nucleus Accumbens; Protein Kinase C; Protein Kinase Inhibitors; Psychotropic Drugs; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Synaptosomes; Tamoxifen; Tritium | 2017 |
Tamoxifen Directly Interacts with the Dopamine Transporter.
Topics: Amphetamine; Animals; Binding Sites; Cell Line; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Rats; Swine; Synaptosomes; Tamoxifen | 2018 |